These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 689736)
81. In vitro inhibition of human peripheral blood lymphocyte transformation by an extract of Pseudomonas putida. Hunt CV; Khan W; Friedman G; Houck JC Immunology; 1977 Aug; 33(2):209-15. PubMed ID: 608686 [TBL] [Abstract][Full Text] [Related]
82. Inhibitory effects of oral Actinomyces on the proliferation, virulence and biofilm formation of Candida albicans. Guo Y; Wei C; Liu C; Li D; Sun J; Huang H; Zhou H Arch Oral Biol; 2015 Sep; 60(9):1368-74. PubMed ID: 26143096 [TBL] [Abstract][Full Text] [Related]
83. Inhibiting effects of Streptococcus salivarius on competence-stimulating peptide-dependent biofilm formation by Streptococcus mutans. Tamura S; Yonezawa H; Motegi M; Nakao R; Yoneda S; Watanabe H; Yamazaki T; Senpuku H Oral Microbiol Immunol; 2009 Apr; 24(2):152-61. PubMed ID: 19239643 [TBL] [Abstract][Full Text] [Related]
84. Growth of oral Streptococcus species and Actinomyces viscosus in human saliva. de Jong MH; van der Hoeven JS; van OS JH; Olijve JH Appl Environ Microbiol; 1984 May; 47(5):901-4. PubMed ID: 6742834 [TBL] [Abstract][Full Text] [Related]
85. Influence of oral bacteria on adhesion of Streptococcus mutans and Streptococcus sanguinis to dental materials. Nabert-Georgi C; Rodloff AC; Jentsch H; Reissmann DR; Schaumann R; Stingu CS Clin Exp Dent Res; 2018 Jun; 4(3):72-77. PubMed ID: 29955390 [TBL] [Abstract][Full Text] [Related]
86. [Antimicrobial activity of N-alkylethylenediamines against oral and other microorganisms]. Ueda M; Murata Y Yakugaku Zasshi; 1989 Mar; 109(3):184-7. PubMed ID: 2754620 [TBL] [Abstract][Full Text] [Related]
87. Degradation of starch and its hydrolytic products by oral bacteria. Glor EB; Miller CH; Spandau DF J Dent Res; 1988 Jan; 67(1):75-81. PubMed ID: 11039050 [TBL] [Abstract][Full Text] [Related]
94. Evidence for the synthesis and release of strongly immunosuppressive, noncytotoxic substances by Streptococcus intermedius. Arala-Chaves MP; Higerd TB; Porto MT; Munoz J; Goust JM; Fudenberg HH; Loadholt CB J Clin Invest; 1979 Oct; 64(4):871-83. PubMed ID: 383749 [TBL] [Abstract][Full Text] [Related]
95. Inhibitory effects of extracellular products from oral bacteria on human fibroblasts and stimulated lymphocytes. Higerd TB; Vesole DH; Goust JM Infect Immun; 1978 Aug; 21(2):567-74. PubMed ID: 689736 [TBL] [Abstract][Full Text] [Related]
96. Inhibition of [3H]-thymidine uptake in human gingival fibroblasts by extracts from human dental plaque, oral bacteria of the Streptococcus and Actinomyces species. Duguid R Arch Oral Biol; 1985; 30(1):89-91. PubMed ID: 3857891 [TBL] [Abstract][Full Text] [Related]
97. Glucose uptake by Streptococcus mutans, Streptococcus mitis, and Actinomyces viscosus in the presence of human saliva. Germaine GR; Tellefson LM Infect Immun; 1982 Dec; 38(3):1060-7. PubMed ID: 7152663 [TBL] [Abstract][Full Text] [Related]
98. Influence of growth medium on adsorption of Streptococcus mutans, Actinomyces viscosus, and Actinomyces naeslundii to saliva-treated hydroxyapatite surfaces. Peros WJ; Gibbons RJ Infect Immun; 1981 Apr; 32(1):111-7. PubMed ID: 7216480 [TBL] [Abstract][Full Text] [Related]
99. Selective binding of blood group-reactive salivary mucins by Streptococcus mutans and other oral organisms. Gibbons RJ; Qureshi JV Infect Immun; 1978 Dec; 22(3):665-71. PubMed ID: 310426 [TBL] [Abstract][Full Text] [Related]